Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. (Q51328729)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 August 2012

Language	Label	Description	Also known as
English	Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial.	scientific article published on 29 August 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

atrial fibrillation

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Christopher B. Granger

11

object named as

Christopher B Granger

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

12

object named as

Lars Wallentin

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

3

object named as

Laine Thomas

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

Renato Delascio Lopes

9

object named as

Renato D Lopes

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

John H. Alexander

4

object named as

John H Alexander

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

Stefan H Hohnloser

1

object named as

Stefan H Hohnloser

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

2

object named as

Ziad Hijazi

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

8

object named as

Fernando Lanas

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

5

object named as

John Amerena

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

7

object named as

Matyas Keltai

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

Jose Luis López-Sendón Moreno

10

object named as

Jose Lopez-Sendon

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

6

object named as

Michael Hanna

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

publication date

29 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

33

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

22

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

2821-2830

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

Prevalence of chronic kidney disease in the United States

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Elevated risk of stroke among patients with end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Quality of care for atrial fibrillation among patients hospitalized for heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

A new equation to estimate glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Biochemical indicators of cardiac and renal function in a healthy elderly population.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Dilemmas in the management of atrial fibrillation in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Chronic kidney disease in octogenarians

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHS274

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHS274

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

release_vro722izyrd6jkidyjl25747fi

1 reference

https://api.fatcat.wiki/v0/release/vro722izyrd6jkidyjl25747fi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/22933567

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51328729&oldid=1936045403"